ANDA 214442, held by Aiping Pharm Inc. Captopril.
As of Nov 13, 2026, ANDA 214442 (Captopril), held by Aiping Pharm Inc, was first approved by FDA on Jan 27, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 27, 2023 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
